Form 6-K Acasti Pharma Inc. For: May 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- S&P Global explores potential separation of Capital IQ business
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Acasti Pharma (ACST) Reports Q1 Loss of $0.18
May 25, 2016 5:10 PM EDTAcasti Pharma (NASDAQ: ACST) reported Q1 EPS of ($0.18), versus ($0.21) reported last year. Revenue for the quarter came in at $21 thousand, versus $178 thousand reported last year.
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
... More


